ArticleScientific data2025
An open bone marrow megakaryocyte dataset for automated morphologic studies.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Megakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications.Biomarker research · 2026Review
- An open bone marrow megakaryocyte dataset for automated morphologic studies.Scientific data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Precise classification of megakaryocyte subtypes in bone marrow examination is crucial for the diagnosis and research of various hematological disorders, including Myelodysplastic Syndromes (MDS) and other platelet-production related diseases. While deep learning (DL) has demonstrated remarkable success in medical image classification, its application to megakaryocyte classification has been hindered by the scarcity of high-quality, openly licensed datasets. Therefore, we present MK-11, a dataset comprising 7,204 Wright-Giemsa stained single-cell images across 11 clinically relevant megakaryocyte subtypes. All images were annotated by two experienced hematopathologists with consensus review to ensure annotation quality, following standardized diagnostic criteria. Several state-of-the-art neural networks, including convolutional and transformer-based models, were evaluated on this benchmark, establishing strong baseline performance for megakaryocyte classification. To ensure reproducibility, we provide standardized five-fold cross-validation partitions along with all original images, annotations, partitioning schemes, and evaluation scripts under open licenses. In conclusion, this work presents the first public megakaryocyte subtype classification dataset for automatic morphological assessment development and evaluation, serving as a benchmark for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.